RFK Jr Report, Constitution Suspended, War Time Procedures in Place, WHO Exit, DOD w/ Sasha Latypova

Sasha Latypova joins the program to present her in-depth research into the Department of Defense’s involvement in the COVID-19 response. She explores how the nation was fundamentally reshaped by the laws, procedures, and frameworks put in place to manage the pandemic as a coordinated operation. Asha also reveals new findings and shares key insights from the report she personally delivered to RFK Jr. and Senator Ron Johnson. You can follow her work at https://sashalatypova.substack.com/

Links mentioned in the show:

• Peptide: Dramatically and safely lose weight: Purchase natural and safe GLP-1 Peptides at https://www.limitlesslifenootropics.com/sarah – Use code sarah to save 10%
• Learn more about SLU-PP-332, mimics exercise & has dramatic weight loss effects: https://sarahwestall.substack.com/p/ground-breaking-compound-mimics-exercise
• MasterPeace: Remove Heavy Metals including Graphene Oxide and Plastics at https://masterpeacebyhcs.com/shop/?ref=11308
• Its important to protect your assets. Don’t buy retail online. Instead contact Miles Franklin by email at [email protected], tell them “Sarah Sent Me” and get access to their private price list

Consider subscribing:

• Follow on TwitterX @Sarah_Westall
• Follow on my Substack at SarahWestall.Substack.com

MUSIC CREDITS: “In Epic World” by Valentina Gribanova, licensed for broad internet media use, including video and audio

See on Bastyon | Bitchute | Brighteon | Clouthub | Odysee | Rumble | Youtube | Tube.Freedom.Buzz

Sasha Latypova Biography

Sasha Latypova is a former pharmaceutical R&D executive. She worked in the industry for 25 years, and ultimately owned and managed several contract research organizations working on clinical trials for 60+pharma companies, including Pfizer, AstraZeneca, J&J, GSK, Novartis and many others. She worked many years in cardiovascular safety assessments and interacted with the FDA and other regulatory agencies on these matters on behalf of her clients and as part of the FDA Cardiovascular Safety Research Consortium.